These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23235)

  • 41. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.
    Uchida Y; Nakamura M; Shimizu S; Shirasawa Y; Fujii M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):132-49. PubMed ID: 6135395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of beta-adrenoceptors mediating renin release produced by isoproterenol in conscious dogs.
    Himori N; Izumi A; Ishimori T
    Am J Physiol; 1980 May; 238(5):F387-93. PubMed ID: 6103674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pamatolol: phase I evaluation of the pharmacodynamics of a cardioselective beta adrenoceptor blocking drug.
    Carruthers SG; Hosler JP; Pentikainen P; Azarnoff DL
    Clin Pharmacol Ther; 1978 Aug; 24(2):168-74. PubMed ID: 28193
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence that beta 1-adrenoceptor activation mediates isoproterenol-stimulated renin secretion in the rat.
    Churchill PC; Churchill MC; McDonald FD
    Endocrinology; 1983 Aug; 113(2):687-92. PubMed ID: 6307647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beta-blockers and the kidney.
    Epstein M; Oster JR
    Miner Electrolyte Metab; 1982 Nov; 8(5):237-54. PubMed ID: 6132329
    [No Abstract]   [Full Text] [Related]  

  • 46. [Antihypertensive effects of timolol and of the combination timolol, amiloride and hydrochlorothiazide].
    Cospite M; Ferrara F; Raimondi F; Lo Presti T; Ballo M; Milio G; Meli F
    Clin Ter; 1981 Sep; 98(6):617-26. PubMed ID: 7026143
    [No Abstract]   [Full Text] [Related]  

  • 47. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cardiovascular effects of timolol, carteolol, metipranolol, betaxolol collyres in the aged patient].
    Le Jeunne C; Bringer L; Mondjee-Tahura Z; Munera Y; Hugues FC
    Therapie; 1988; 43(2):89-92. PubMed ID: 2900562
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of D-timolol on intraocular pressure, heart rate, cardiac contractility, and tracheal muscle function.
    Chiou GC
    Curr Eye Res; 1982-1983; 2(8):507-10. PubMed ID: 7184703
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic differences between single and multiple oral dosing with the guidance for beta-adrenoceptor blockade assessment.
    Ishizaki T; Tawara K
    Cardiology; 1979; 64 Suppl 1():25-43. PubMed ID: 42487
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of cardiac effects of timolol and propranolol.
    Achong MR; Piafsky KM; Ogilvie RI
    Clin Pharmacol Ther; 1975 Sep; 18(3):278-86. PubMed ID: 1100298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacologic evaluation of CI-775, a cardioselective beta adrenergic antagonist.
    Hastings SG; Smith RD; Corey RM; Essenburg AD; Pettway CE; Tessman DK
    Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):81-99. PubMed ID: 17372
    [No Abstract]   [Full Text] [Related]  

  • 55. A sensitive radioligand binding assay for timolol in plasma.
    Kaila T
    J Pharm Sci; 1991 Mar; 80(3):296-9. PubMed ID: 1675681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antihypertensive effects of tolamolol.
    Vlachakis ND; Mendlowitz M; Krakoff LR
    Clin Pharmacol Ther; 1977 Jan; 21(1):9-15. PubMed ID: 318950
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Letter: Beta receptors and renin release.
    Amery A; Billiet L; Fagard R
    N Engl J Med; 1974 Jan; 290(5):284. PubMed ID: 4148766
    [No Abstract]   [Full Text] [Related]  

  • 58. [Hemodynamic action of talinolol (Cordanum, 02-115), a new beta-receptor blocking substance, in man].
    Wolf P; Feller K; Femmer K
    Pharmazie; 1975 Oct; 30(10):678-81. PubMed ID: 696
    [No Abstract]   [Full Text] [Related]  

  • 59. Suppression of renin release by timolol.
    Graham RM; Oates HF; Weber MA; Stokes GS
    Arch Int Pharmacodyn Ther; 1976 Feb; 219(2):205-10. PubMed ID: 5974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.